Trial intelligence / Profile preview

Trazodone for neuroleptic-induced acute akathisia

IRCT20191218045795N1Phase 3Completed

Sponsor
Kurdistan University of Medical Sciences
Start
Feb 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of trazodone in akathisia (2 arms), sponsored by Kurdistan University of Medical Sciences. Primary endpoints: Barnes Akathisia Rating Scale score and Akathisia. Started Feb 2019; status: completed.

02

Drugs

trazodone
03

Conditions

akathisia

Beyond the preview

Go deeper on IRCT20191218045795N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20191218045795N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call